Variant report

Variant	rs199591609
Chromosome Location	chr12:50368630-50368631
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:13)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:50368103..50369610-chr12:50371234..50372946,2	K562	blood:
2	chr12:50367636..50371210-chr12:50373031..50375237,3	K562	blood:
3	chr12:50015023..50017139-chr12:50367561..50369518,2	K562	blood:
4	chr12:50368132..50368664-chr12:50463988..50464856,2	K562	blood:
5	chr12:50361097..50363136-chr12:50368065..50369960,2	MCF-7	breast:
6	chr12:50258974..50260618-chr12:50366779..50369622,2	MCF-7	breast:
7	chr12:50368076..50369916-chr12:50370500..50372771,2	MCF-7	breast:
8	chr12:50367709..50369586-chr12:50462445..50464458,2	MCF-7	breast:
9	chr12:50367042..50370413-chr12:50441830..50446012,4	K562	blood:
10	chr12:50366961..50368712-chr12:50409103..50412073,2	K562	blood:
11	chr12:50367696..50368951-chr12:50463985..50464557,3	MCF-7	breast:
12	chr12:50367707..50368705-chr12:50449431..50450774,7	MCF-7	breast:
13	chr12:50368102..50368945-chr12:50449516..50450250,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000161800	Chromatin interaction
ENSG00000110881	Chromatin interaction

Extended variants
information (count: 12 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1045327	chr12:49975040-50551375	Strong transcription Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	170 gene(s)	inside rSNPs	diseases
2	nsv541490	chr12:49975040-50551375	Weak transcription Transcr. at gene 5' and 3' Enhancers Genic enhancers Active TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	170 gene(s)	inside rSNPs	diseases
3	nsv522972	chr12:50196394-50410831	Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
4	nsv530671	chr12:50233858-50708991	Flanking Active TSS Active TSS Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	117 gene(s)	inside rSNPs	diseases
5	nsv832407	chr12:50243268-50412236	Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
6	nsv558835	chr12:50275137-50433234	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
7	nsv899072	chr12:50326176-50379667	Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
8	esv1827130	chr12:50349765-50379667	Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
9	nsv469374	chr12:50349765-50467769	Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
10	nsv469375	chr12:50349765-50467769	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
11	nsv558837	chr12:50349765-50467769	Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
12	esv3367643	chr12:50368496-50368802	Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:50361400-50372800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr12:50362000-50371200	Weak transcription	Fetal Brain Female	brain
3	chr12:50362600-50385800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr12:50364200-50371000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr12:50365800-50369200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr12:50366200-50369800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr12:50366400-50374600	Weak transcription	Fetal Kidney	kidney
8	chr12:50366600-50368800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr12:50366600-50377400	Weak transcription	NHEK	skin
10	chr12:50366800-50369200	Enhancers	Liver	Liver
11	chr12:50367000-50369600	Enhancers	Fetal Intestine Large	intestine
12	chr12:50367000-50369800	Enhancers	Fetal Intestine Small	intestine
13	chr12:50367000-50378000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr12:50367200-50369200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
15	chr12:50367400-50369000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr12:50367400-50369000	Flanking Bivalent TSS/Enh	HepG2	liver
17	chr12:50367400-50401200	Weak transcription	Gastric	stomach
18	chr12:50367600-50369200	Enhancers	Duodenum Mucosa	Duodenum
19	chr12:50367600-50374800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr12:50367800-50368800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
21	chr12:50367800-50369200	Enhancers	Rectal Smooth Muscle	rectum
22	chr12:50367800-50369200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
23	chr12:50367800-50370000	Enhancers	Fetal Heart	heart
24	chr12:50367800-50370800	Enhancers	Cortex derived primary cultured neurospheres	brain
25	chr12:50368000-50369400	Enhancers	Fetal Muscle Leg	muscle
26	chr12:50368000-50369400	Enhancers	Placenta	Placenta
27	chr12:50368000-50369600	Enhancers	Ovary	ovary
28	chr12:50368000-50372000	Enhancers	Brain Germinal Matrix	brain
29	chr12:50368200-50368800	Flanking Active TSS	Brain Anterior Caudate	brain
30	chr12:50368200-50368800	Flanking Active TSS	Brain Substantia Nigra	brain
31	chr12:50368200-50368800	Enhancers	Lung	lung
32	chr12:50368200-50369000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr12:50368200-50369200	Enhancers	Adipose Nuclei	Adipose
34	chr12:50368200-50369200	Enhancers	Fetal Lung	lung
35	chr12:50368200-50369200	Enhancers	Right Ventricle	heart
36	chr12:50368200-50369400	Flanking Active TSS	Stomach Smooth Muscle	stomach
37	chr12:50368200-50369600	Enhancers	Primary monocytes fromperipheralblood	blood
38	chr12:50368200-50369800	Enhancers	Fetal Brain Male	brain
39	chr12:50368200-50370000	Enhancers	Duodenum Smooth Muscle	Duodenum
40	chr12:50368200-50370000	Enhancers	Fetal Stomach	stomach
41	chr12:50368400-50368800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
42	chr12:50368400-50368800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr12:50368400-50368800	Enhancers	Fetal Thymus	thymus
44	chr12:50368400-50369600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr12:50368400-50374600	Weak transcription	Pancreas	Pancrea
46	chr12:50368400-50376000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr12:50368600-50368800	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr12:50368600-50368800	Bivalent Enhancer	Stomach Mucosa	stomach
49	chr12:50368600-50368800	Enhancers	GM12878-XiMat	blood
50	chr12:50368600-50369000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links